GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | 10/30/2026 6:12:16 AM | Large | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $8,300,000,000 +6.8% | Assets $51,408,000,000 | EPS $1.94 | |
| GILEAD SCIENCES, INC. (GILD) | 10/29/2026 4:07:27 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $8,300,000,000 +6.8% | Assets $51,408,000,000 | EPS $1.94 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 8/6/2026 4:28:03 PM | Large | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $7,803,000,000 +10.2% | Assets $49,362,000,000 | EPS -$8.45 | |
| GILEAD SCIENCES, INC. (GILD) | 8/4/2026 4:07:30 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $7,803,000,000 +10.2% | Assets $49,362,000,000 | EPS -$8.45 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 5/7/2026 5:21:55 PM | Large | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $6,960,000,000 +4.4% | Assets $56,278,000,000 | EPS $1.61 | |
| GILEAD SCIENCES, INC. (GILD) | 5/7/2026 4:05:39 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $6,960,000,000 +4.4% | Assets $56,278,000,000 | EPS $1.61 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 3/20/2026 4:06:09 PM | View | Proxy | SEC | Y 2025 | ||||||
| GILEAD SCIENCES, INC. (GILD) | 2/24/2026 4:23:27 PM | Large | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $29,443,000,000 +2.4% | Assets $59,023,000,000 | EPS $6.78 | |
| GILEAD SCIENCES, INC. (GILD) | 2/10/2026 4:03:29 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $7,925,000,000 +4.7% | Assets $59,023,000,000 | EPS $1.74 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 11/7/2025 4:15:56 PM | Large | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $7,769,000,000 +3.0% | Assets $58,533,000,000 | EPS $2.43 | |
| GILEAD SCIENCES, INC. (GILD) | 10/30/2025 4:05:46 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $7,769,000,000 +3.0% | Assets $58,533,000,000 | EPS $2.43 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 8/7/2025 5:22:18 PM | Large | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $7,082,000,000 +1.8% | Assets $55,721,000,000 | EPS $1.56 | |
| GILEAD SCIENCES, INC. (GILD) | 8/7/2025 4:34:05 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $7,082,000,000 +1.8% | Assets $55,721,000,000 | EPS $1.56 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 5/7/2025 4:42:37 PM | Large | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $6,667,000,000 -0.3% | Assets $56,434,000,000 | EPS $1.04 | |
| GILEAD SCIENCES, INC. (GILD) | 4/24/2025 4:08:50 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $6,667,000,000 -0.3% | Assets $56,434,000,000 | EPS $1.04 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 3/27/2025 4:31:27 PM | View | Proxy | SEC | Y 2024 | ||||||
| GILEAD SCIENCES, INC. (GILD) | 2/28/2025 4:34:55 PM | Large | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $28,754,000,000 +6.0% | Assets $58,995,000,000 | EPS $0.38 | |
| GILEAD SCIENCES, INC. (GILD) | 2/11/2025 4:05:25 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $7,569,000,000 +6.4% | Assets $58,995,000,000 | EPS $1.42 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 11/12/2024 9:43:43 AM | Large | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $7,545,000,000 +7.0% | Assets $54,525,000,000 | EPS $1.00 | |
| GILEAD SCIENCES, INC. (GILD) | 11/6/2024 4:12:38 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $7,545,000,000 +7.0% | Assets $54,525,000,000 | EPS $1.00 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 8/8/2024 5:29:11 PM | Large | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $6,954,000,000 +5.4% | Assets $53,579,000,000 | EPS $1.29 | |
| GILEAD SCIENCES, INC. (GILD) | 8/8/2024 4:08:58 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $6,954,000,000 +5.4% | Assets $53,579,000,000 | EPS $1.29 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 5/8/2024 5:06:29 PM | Large | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $6,686,000,000 +5.3% | Assets $56,292,000,000 | EPS -$3.34 | |
| GILEAD SCIENCES, INC. (GILD) | 4/25/2024 4:13:54 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $6,686,000,000 +5.3% | Assets $56,292,000,000 | EPS -$3.34 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 3/28/2024 4:15:07 PM | View | Proxy | SEC | Y 2023 | ||||||
| GILEAD SCIENCES, INC. (GILD) | 2/23/2024 5:17:22 PM | Large | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $27,116,000,000 -0.6% | Assets $62,125,000,000 | EPS $4.50 | |
| GILEAD SCIENCES, INC. (GILD) | 2/6/2024 4:05:01 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $7,114,000,000 -3.7% | Assets $62,125,000,000 | EPS $1.13 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 11/7/2023 5:24:48 PM | Large | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $7,051,000,000 +0.1% | Assets $62,373,000,000 | EPS $1.73 | |
| GILEAD SCIENCES, INC. (GILD) | 11/7/2023 4:04:17 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $7,051,000,000 +0.1% | Assets $62,373,000,000 | EPS $1.73 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 8/4/2023 4:17:08 PM | Large | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $6,599,000,000 +5.4% | Assets $62,337,000,000 | EPS $0.83 | |
| GILEAD SCIENCES, INC. (GILD) | 8/3/2023 4:09:37 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $6,599,000,000 +5.4% | Assets $62,337,000,000 | EPS $0.83 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 5/3/2023 4:21:01 PM | Large | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $6,352,000,000 -3.6% | Assets $61,876,000,000 | EPS $0.80 | |
| GILEAD SCIENCES, INC. (GILD) | 4/27/2023 4:12:50 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $6,352,000,000 -3.6% | Assets $61,876,000,000 | EPS $0.80 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 4/5/2023 4:03:34 PM | View | Proxy | SEC | Y 2022 | ||||||
| GILEAD SCIENCES, INC. (GILD) | 3/23/2023 4:13:08 PM | View | Proxy | SEC | Y 2022 | ||||||
| GILEAD SCIENCES, INC. (GILD) | 2/22/2023 4:28:08 PM | Large | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $27,281,000,000 -0.1% | Assets $63,171,000,000 | EPS $3.64 | |
| GILEAD SCIENCES, INC. (GILD) | 2/2/2023 4:05:36 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $7,389,000,000 +2.0% | Assets $63,171,000,000 | EPS $1.30 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 11/2/2022 5:18:42 PM | Large | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $7,042,000,000 -5.1% | Assets $62,557,000,000 | EPS $1.42 | |
| GILEAD SCIENCES, INC. (GILD) | 10/27/2022 4:07:15 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $7,042,000,000 -5.1% | Assets $62,557,000,000 | EPS $1.42 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 8/8/2022 4:59:06 PM | Large | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $6,260,000,000 +0.7% | Assets $62,870,000,000 | EPS $0.91 | |
| GILEAD SCIENCES, INC. (GILD) | 8/2/2022 4:07:38 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $6,260,000,000 +0.7% | Assets $62,870,000,000 | EPS $0.91 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 5/4/2022 4:37:21 PM | Large | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $6,590,000,000 +2.6% | Assets $63,080,000,000 | EPS $0.02 | |
| GILEAD SCIENCES, INC. (GILD) | 4/28/2022 4:12:22 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $6,590,000,000 +2.6% | Assets $63,080,000,000 | EPS $0.02 | Export Earnings Model | |
| GILEAD SCIENCES, INC. (GILD) | 3/24/2022 4:07:28 PM | View | Proxy | SEC | Y 2021 | ||||||
| GILEAD SCIENCES, INC. (GILD) | 2/23/2022 5:03:17 PM | Large | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $27,305,000,000 +10.6% | Assets $67,952,000,000 | EPS $4.93 | |
| GILEAD SCIENCES INC (GILD) | 2/1/2022 4:08:44 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $7,244,000,000 -2.4% | Assets $67,952,000,000 | EPS $0.30 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/3/2021 4:41:33 PM | Large | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $7,421,000,000 +12.8% | Assets $67,098,000,000 | EPS $2.05 | |
| GILEAD SCIENCES INC (GILD) | 10/28/2021 4:11:20 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $7,421,000,000 +12.8% | Assets $67,098,000,000 | EPS $2.05 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/5/2021 4:26:00 PM | Large | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $6,217,000,000 +20.9% | Assets $67,984,000,000 | EPS $1.21 | |
| GILEAD SCIENCES INC (GILD) | 7/29/2021 4:10:49 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $6,217,000,000 +20.9% | Assets $67,984,000,000 | EPS $1.21 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/6/2021 4:25:50 PM | Large | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $6,423,000,000 +15.8% | Assets $67,492,000,000 | EPS $1.37 | |
| GILEAD SCIENCES INC (GILD) | 4/29/2021 4:10:44 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $6,423,000,000 +15.8% | Assets $67,492,000,000 | EPS $1.37 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/30/2021 5:24:19 PM | View | Proxy | SEC | Y 2020 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/25/2021 4:21:50 PM | Large | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $24,689,000,000 +10.0% | Assets $68,407,000,000 | EPS $0.10 | |
| GILEAD SCIENCES INC (GILD) | 2/4/2021 4:06:10 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $7,421,000,000 +26.2% | Assets $68,407,000,000 | EPS $1.23 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 1/11/2021 6:05:25 AM | View | Guidance Update | SEC | Y 2021 | ||||||
| GILEAD SCIENCES INC (GILD) | 11/4/2020 6:16:39 AM | Large | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $6,577,000,000 +17.4% | Assets $60,878,000,000 | EPS $0.29 | |
| GILEAD SCIENCES INC (GILD) | 10/28/2020 4:15:32 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $6,577,000,000 +17.4% | Assets $60,878,000,000 | EPS $0.29 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/6/2020 4:20:52 PM | Large | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $5,143,000,000 -9.5% | Assets $55,934,000,000 | EPS -$2.66 | |
| GILEAD SCIENCES INC (GILD) | 7/30/2020 6:59:24 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $5,143,000,000 -9.5% | Assets $55,934,000,000 | EPS -$2.66 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/6/2020 6:11:42 AM | Large | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $5,548,000,000 +5.1% | Assets $59,741,000,000 | EPS $1.22 | |
| GILEAD SCIENCES INC (GILD) | 4/30/2020 4:10:11 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $5,548,000,000 +5.1% | Assets $59,741,000,000 | EPS $1.22 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/24/2020 4:07:02 PM | View | Proxy | SEC | Y 2019 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/25/2020 6:32:14 AM | Large | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $22,449,000,000 +1.5% | Assets $61,627,000,000 | EPS $4.22 | |
| GILEAD SCIENCES INC (GILD) | 2/4/2020 4:09:30 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $5,879,000,000 +1.4% | Assets $61,627,000,000 | EPS $2.12 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/5/2019 5:43:14 PM | Large | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $5,604,000,000 +0.1% | Assets $59,146,000,000 | EPS -$0.92 | |
| GILEAD SCIENCES INC (GILD) | 10/25/2019 6:03:45 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $5,604,000,000 +0.1% | Assets $59,146,000,000 | EPS -$0.92 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/6/2019 4:56:48 PM | Large | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $5,685,000,000 +0.7% | Assets $63,210,000,000 | EPS $1.47 | |
| GILEAD SCIENCES INC (GILD) | 7/30/2019 4:16:59 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $5,685,000,000 +0.7% | Assets $63,210,000,000 | EPS $1.47 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/8/2019 6:43:27 AM | Large | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $5,281,000,000 +3.8% | Assets $62,837,000,000 | EPS $1.54 | |
| GILEAD SCIENCES INC (GILD) | 5/2/2019 4:06:56 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $5,281,000,000 +3.8% | Assets $62,837,000,000 | EPS $1.54 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/25/2019 4:08:01 PM | View | Proxy | SEC | Y 2018 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/26/2019 6:09:11 AM | Large | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $22,127,000,000 -15.2% | Assets $63,675,000,000 | EPS $4.17 | |
| GILEAD SCIENCES INC (GILD) | 2/4/2019 4:06:53 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $5,795,000,000 -2.6% | Assets $63,675,000,000 | EPS $0.02 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/6/2018 4:27:58 PM | Large | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $5,596,000,000 -14.1% | Assets $64,305,000,000 | EPS $1.60 | |
| GILEAD SCIENCES INC (GILD) | 10/25/2018 4:14:45 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $5,596,000,000 -14.1% | Assets $64,305,000,000 | EPS $1.60 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/6/2018 4:29:31 PM | Large | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $5,648,000,000 -20.9% | Assets $65,355,000,000 | EPS $1.39 | |
| GILEAD SCIENCES INC (GILD) | 7/25/2018 4:06:09 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $5,648,000,000 -20.9% | Assets $65,355,000,000 | EPS $1.39 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/9/2018 6:08:12 AM | Large | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $5,088,000,000 -21.8% | Assets $65,381,000,000 | EPS $1.17 | |
| GILEAD SCIENCES INC (GILD) | 5/1/2018 4:05:51 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $5,088,000,000 -21.8% | Assets $65,381,000,000 | EPS $1.17 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/26/2018 4:24:06 PM | View | Proxy | SEC | Y 2017 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/27/2018 6:13:35 AM | Large | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $26,107,000,000 -14.1% | Assets $70,283,000,000 | EPS $3.51 | |
| GILEAD SCIENCES INC (GILD) | 2/6/2018 4:07:54 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $5,949,000,000 -18.7% | Assets $70,283,000,000 | EPS -$2.96 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/7/2017 6:08:35 AM | Large | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $6,512,000,000 -13.2% | Assets $64,662,000,000 | EPS $2.06 | |
| GILEAD SCIENCES INC (GILD) | 10/26/2017 4:06:36 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $6,512,000,000 -13.2% | Assets $64,662,000,000 | EPS $2.06 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/7/2017 4:43:40 PM | Large | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $7,141,000,000 -8.2% | Assets $60,263,000,000 | EPS $2.33 | |
| GILEAD SCIENCES INC (GILD) | 7/26/2017 4:04:17 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $7,141,000,000 -8.2% | Assets $60,263,000,000 | EPS $2.33 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/10/2017 6:06:14 AM | Large | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $6,505,000,000 -16.5% | Assets $57,701,000,000 | EPS $2.05 | |
| GILEAD SCIENCES INC (GILD) | 5/2/2017 4:05:30 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $6,505,000,000 -16.5% | Assets $57,701,000,000 | EPS $2.05 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/27/2017 4:40:16 PM | View | Proxy | SEC | Y 2016 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/27/2017 4:23:29 PM | Large | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $30,390,000,000 -6.9% | Assets $56,977,000,000 | EPS $9.94 | |
| GILEAD SCIENCES INC (GILD) | 2/7/2017 4:03:32 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $7,320,000,000 -13.9% | Assets $56,977,000,000 | EPS $2.34 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/7/2016 4:45:11 PM | Large | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $7,500,000,000 -9.6% | Assets $56,609,000,000 | EPS $2.49 | |
| GILEAD SCIENCES INC (GILD) | 11/1/2016 4:05:01 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $7,500,000,000 -9.6% | Assets $56,609,000,000 | EPS $2.49 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/5/2016 4:12:17 PM | Large | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $7,776,000,000 -5.7% | Assets $49,980,000,000 | EPS $2.58 | |
| GILEAD SCIENCES INC (GILD) | 7/25/2016 5:00:52 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $7,776,000,000 -5.7% | Assets $49,980,000,000 | EPS $2.58 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 7/25/2016 4:14:15 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $7,776,000,000 -5.7% | Assets $49,980,000,000 | EPS $2.58 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/6/2016 4:15:07 PM | Large | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $7,794,000,000 +2.6% | Assets $47,765,000,000 | EPS $2.53 | |
| GILEAD SCIENCES INC (GILD) | 4/28/2016 4:05:41 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $7,794,000,000 +2.6% | Assets $47,765,000,000 | EPS $2.53 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/28/2016 2:50:39 PM | View | Proxy | SEC | Y 2015 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/24/2016 5:01:48 PM | Large | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $32,639,000,000 +31.1% | Assets $51,716,000,000 | EPS $11.91 | |
| GILEAD SCIENCES INC (GILD) | 2/2/2016 4:03:45 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $8,506,000,000 +16.3% | Assets $51,716,000,000 | EPS $3.18 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/4/2015 4:02:41 PM | Large | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $8,295,000,000 +37.3% | Assets $50,637,000,000 | EPS $3.06 | |
| GILEAD SCIENCES INC (GILD) | 10/27/2015 4:10:53 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $8,295,000,000 +37.3% | Assets $50,637,000,000 | EPS $3.06 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/5/2015 4:19:50 PM | Large | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $8,244,000,000 +26.2% | Assets $39,167,000,000 | EPS $2.92 | |
| GILEAD SCIENCES INC (GILD) | 7/28/2015 4:03:04 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $8,244,000,000 +26.2% | Assets $39,167,000,000 | EPS $2.92 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/8/2015 4:30:06 PM | Large | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $7,594,000,000 +51.9% | Assets $38,321,000,000 | EPS $2.76 | |
| GILEAD SCIENCES INC (GILD) | 4/30/2015 4:03:16 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $7,594,000,000 +51.9% | Assets $38,321,000,000 | EPS $2.76 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/27/2015 1:06:40 PM | View | Proxy | SEC | Y 2014 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/25/2015 4:05:20 PM | Large | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $24,890,000,000 +122.2% | Assets $34,664,000,000 | EPS $7.35 | |
| GILEAD SCIENCES INC (GILD) | 2/3/2015 4:07:19 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $7,314,000,000 +134.4% | Assets $34,664,000,000 | EPS $2.18 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/5/2014 4:28:30 PM | Large | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $6,042,000,000 +117.1% | Assets $28,844,393,000 | EPS $1.67 | |
| GILEAD SCIENCES INC (GILD) | 10/28/2014 4:08:02 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $6,042,000,000 +117.1% | Assets $28,844,393,000 | EPS $1.67 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/4/2014 5:19:21 PM | Large | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $6,535,000,000 +136.2% | Assets $31,206,164,000 | EPS $2.20 | |
| GILEAD SCIENCES INC (GILD) | 7/23/2014 4:08:03 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $6,535,000,000 +136.2% | Assets $31,206,164,000 | EPS $2.20 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/7/2014 5:19:48 PM | Large | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $4,999,000,000 +97.4% | Assets $28,077,692,000 | EPS $1.33 | |
| GILEAD SCIENCES INC (GILD) | 4/22/2014 4:07:28 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $4,999,000,000 +97.4% | Assets $28,077,692,000 | EPS $1.33 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/24/2014 5:14:03 PM | View | Proxy | SEC | Y 2013 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/25/2014 4:10:01 PM | Large | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $11,202,000,000 +15.5% | Assets $22,579,000,000 | EPS $1.81 | |
| GILEAD SCIENCES INC (GILD) | 2/4/2014 4:09:47 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $3,120,000,000 +20.5% | Assets $22,579,000,000 | EPS $0.47 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 10/31/2013 4:40:08 PM | Large | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $2,783,000,000 +14.7% | Assets $22,468,428,000 | EPS $0.47 | |
| GILEAD SCIENCES INC (GILD) | 10/29/2013 4:08:35 PM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $2,783,000,000 +14.7% | Assets $22,468,428,000 | EPS $0.47 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/1/2013 4:11:19 PM | Large | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $2,767,000,000 +15.0% | Assets $22,624,374,000 | EPS $0.46 | |
| GILEAD SCIENCES INC (GILD) | 7/25/2013 4:09:42 PM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $2,767,000,000 +15.0% | Assets $22,624,374,000 | EPS $0.46 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/8/2013 5:15:40 PM | Large | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $2,532,000,000 +10.9% | Assets $22,211,668,000 | EPS $0.43 | |
| GILEAD SCIENCES INC (GILD) | 5/2/2013 4:11:30 PM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $2,532,000,000 +10.9% | Assets $22,211,668,000 | EPS $0.43 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/20/2013 5:28:10 PM | View | Proxy | SEC | Y 2012 | ||||||
| GILEAD SCIENCES INC (GILD) | 3/19/2013 4:47:05 PM | View | Proxy | SEC | Y 2012 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/27/2013 4:36:05 PM | Large | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $9,702,000,000 +15.7% | Assets $21,239,838,000 | EPS $1.64 | |
| GILEAD SCIENCES INC (GILD) | 2/4/2013 4:13:14 PM | View | Financials | Earnings | SEC | Y 2012 | Rev $2,588,285,000 +17.6% | Assets $21,239,838,000 | EPS $0.47 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/6/2012 4:06:03 PM | Large | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $2,426,597,000 +14.4% | Assets $20,963,829,000 | EPS $0.43 | |
| GILEAD SCIENCES INC (GILD) | 10/23/2012 4:06:55 PM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $2,426,597,000 +14.4% | Assets $20,963,829,000 | EPS $0.43 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/1/2012 3:58:47 PM | Large | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $2,405,186,000 +12.5% | Assets $20,501,950,000 | EPS $0.46 | |
| GILEAD SCIENCES INC (GILD) | 7/26/2012 4:09:36 PM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $2,405,186,000 +12.5% | Assets $20,501,950,000 | EPS $0.46 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/4/2012 4:26:19 PM | Large | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $2,282,449,000 +18.5% | Assets $19,950,386,000 | EPS $0.28 | |
| GILEAD SCIENCES INC (GILD) | 4/26/2012 4:21:16 PM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $2,282,449,000 +18.5% | Assets $19,950,386,000 | EPS $0.28 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/20/2012 3:29:14 PM | View | Proxy | SEC | Y 2011 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/23/2012 4:18:06 PM | Large | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $8,385,385,000 +5.5% | Assets $17,303,134,000 | EPS $1.77 | |
| GILEAD SCIENCES INC (GILD) | 2/2/2012 4:15:33 PM | View | Financials | Earnings | SEC | Y 2011 | Rev $2,200,378,000 +10.1% | Assets $17,303,134,000 | EPS $0.43 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/4/2011 4:50:58 PM | Large | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $2,121,660,000 +9.5% | Assets $12,639,898,000 | EPS $0.47 | |
| GILEAD SCIENCES INC (GILD) | 10/27/2011 4:27:06 PM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $2,121,660,000 +9.5% | Assets $12,639,898,000 | EPS $0.47 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/5/2011 4:48:22 PM | Large | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $2,137,253,000 +10.9% | Assets $12,694,140,000 | EPS $0.47 | |
| GILEAD SCIENCES INC (GILD) | 7/26/2011 4:25:59 PM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $2,137,253,000 +10.9% | Assets $12,694,140,000 | EPS $0.47 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/9/2011 4:35:41 PM | Large | View | Financials | 10-Q | SEC | 1Q 2011 ending: 3/31/2011 | Rev: $1,926,094,000 -7.7% | Assets $12,987,354,000 | EPS $0.40 | |
| GILEAD SCIENCES INC (GILD) | 4/20/2011 4:26:26 PM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $1,926,094,000 -7.7% | Assets $12,987,354,000 | EPS $0.40 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/22/2011 1:20:37 PM | View | Proxy | SEC | Y 2010 | ||||||
| GILEAD SCIENCES INC (GILD) | 2/28/2011 4:40:37 PM | Large | View | Financials | 10-K | SEC | Y 2010 ending: 12/31/2010 | Rev: $7,949,420,000 +13.4% | Assets $11,592,630,000 | EPS $1.66 | |
| GILEAD SCIENCES INC (GILD) | 1/25/2011 4:22:57 PM | View | Financials | Earnings | SEC | Y 2010 | Rev $1,998,687,000 -1.7% | Assets $11,592,630,000 | EPS $0.76 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/8/2010 5:02:32 PM | Large | View | Financials | 10-Q | SEC | 3Q 2010 ending: 9/30/2010 | Rev: $1,937,656,000 +7.6% | Assets $11,455,591,000 | EPS $0.83 | |
| GILEAD SCIENCES INC (GILD) | 10/19/2010 4:20:00 PM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $1,937,656,000 +7.6% | Assets $11,455,591,000 | EPS $0.83 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/9/2010 6:20:57 AM | Large | View | Financials | 10-Q | SEC | 2Q 2010 ending: 6/30/2010 | Rev: $1,927,224,000 +17.0% | Assets $10,496,708,000 | EPS $0.79 | |
| GILEAD SCIENCES INC (GILD) | 7/20/2010 4:23:54 PM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $1,927,224,000 +17.0% | Assets $10,496,708,000 | EPS $0.79 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 5/10/2010 4:16:12 PM | Large | View | Financials | 10-Q | SEC | 1Q 2010 ending: 3/31/2010 | Rev: $2,085,853,000 +36.3% | Assets $10,695,998,000 | EPS $0.92 | |
| GILEAD SCIENCES INC (GILD) | 4/20/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Rev $2,085,853,000 +36.3% | Assets $10,695,998,000 | EPS $0.92 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 3/22/2010 4:53:18 PM | View | Proxy | SEC | Y 2009 | ||||||
| GILEAD SCIENCES INC (GILD) | 3/1/2010 4:28:09 PM | Large | View | Financials | 10-K | SEC | Y 2009 ending: 12/31/2009 | Rev: $7,011,383,000 +31.4% | Assets $9,698,559,000 | EPS $2.82 | |
| GILEAD SCIENCES INC (GILD) | 1/26/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Rev $2,032,379,000 +42.3% | Assets $9,698,559,000 | EPS $0.87 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 11/5/2009 4:44:04 PM | Large | View | Financials | 10-Q | SEC | 3Q 2009 ending: 9/30/2009 | Rev: $1,801,389,000 +31.4% | Assets $8,936,980,000 | EPS $0.72 | |
| GILEAD SCIENCES INC (GILD) | 10/20/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | Rev $1,801,389,000 +31.4% | Assets $8,936,980,000 | EPS $0.72 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 8/5/2009 4:44:30 PM | Large | View | Financials | 10-Q | SEC | 2Q 2009 ending: 6/30/2009 | Rev: $1,647,155,000 +28.9% | Assets $8,387,092,000 | EPS $0.61 | |
| GILEAD SCIENCES INC (GILD) | 7/21/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Rev $1,647,155,000 +28.9% | Assets $8,387,092,000 | EPS $0.61 | Export Earnings Model | |
| GILEAD SCIENCES INC (GILD) | 4/21/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Rev $1,530,460,000 | EPS $0.63 | Export Earnings Model | ||
| GILEAD SCIENCES INC (GILD) | 3/12/2009 5:23:45 PM | View | Proxy | SEC | Y 2008 | ||||||
| GILEAD SCIENCES INC (GILD) | 1/27/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Rev $1,428,205,000 | Assets $6,936,831,000 | EPS $0.59 | Export Earnings Model |